CRCD Performance — T-Rex 2x Inverse Crcl Daily Target ETF

Data updated: 2026-08-26

In the 12 months to Jun 2026 the fund took in a net $7.3M, and assets reached $8.55M.

CRCD Growth of $100

What $100 invested in T-Rex 2x Inverse Crcl Daily Target ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Inverse category average over the same months.

PeriodCRCDCategory average
Since data start (Sep 2025 – Jun 2026)$28$74

CRCD Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD−79.62%

CRCD Annual Returns

Calendar-year total returns of T-Rex 2x Inverse Crcl Daily Target ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jun)−79.62%
2025 (Sep–Dec)+36.99%

CRCD Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+37.2%−73.6%−45.2%−8.0%−55.5%+151.0%——————
2025————————−12.4%−9.2%+102.2%−14.8%

CRCD Risk

Risk measures from monthly returns over Sep 2025 – Jun 2026.

  • Best month: +151.03% (Jun 2026)
  • Worst month: −73.62% (Feb 2026)

CRCD Fund Flows

Monthly money in and out of T-Rex 2x Inverse Crcl Daily Target ETF, from SEC Form N-PORT.

  • 12-month net flow: $7.3M
  • 12-month gross sales (incl. reinvestments): $121.8M
  • Sales ÷ redemptions: 1.06×
MonthSalesRedemptionsNet flow
Jun 2026$4.4M$14.0M−$9.6M
May 2026$33.4M$31.4M$2.0M
Apr 2026$14.4M$16.2M−$1.8M
Mar 2026$33.9M$33.2M$788K
Feb 2026$16.7M$697K$16.0M
Jan 2026$1.6M$2.9M−$1.3M
Dec 2025$6.2M$5.3M$846K
Nov 2025$6.1M$8.0M−$1.9M
Oct 2025$4.8M$2.8M$2.0M
Sep 2025$250K$0$250K

CRCD Assets Under Management

Net assets of T-Rex 2x Inverse Crcl Daily Target ETF by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$8.55M
2026-03-31$13.72M
2025-12-31$3.94M
2025-09-30$218.95K

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.